The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) has been widely accepted in the assessment of diagnostic accuracy and quality. However, it is not suitable for assessing risk of bias in studies comparing diagnostic accuracy. The current common practice in systematic reviews is to derive comparative accuracy from non-comparative diagnostic accuracy studies, which is inherently biased. The QUADAS group developed the QUADAS-Compare (QUADAS-C) tool for assessing the risk of bias in comparative diagnostic accuracy studies. It was officially launched in October 2021. QUADAS-C retains the same 4-domain structure as QUADAS-2: patient selection, index test, reference standard, and flow and timing. It also includes an additional 14 signaling questions and 4 risk of bias questions. This allows researchers to identify high-quality research evidence and avoid bias in research design and conduct. This article interpreted the basic situation, evaluation items, evaluation standards, and usage methods and procedures associated with QUADAS-C to provide references for domestic users.
Citation: HUANG Yuxiang, SHEN Jiantong, LIU Yujin. An introduction to QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies. Chinese Journal of Evidence-Based Medicine, 2022, 22(9): 1108-1116. doi: 10.7507/1672-2531.202204090 Copy
-
Previous Article
Introduction of UK Biobank data application -
Next Article
Changes in the disease burden of ischemic stroke in China from 1990 to 2019